Anticancer, antioxidant, and antibacterial activities of low molecular weight bioactive subfractions isolated from cultures of wood degrading fungus Cerrena unicolor
- PMID: 29874240
- PMCID: PMC5991343
- DOI: 10.1371/journal.pone.0197044
Anticancer, antioxidant, and antibacterial activities of low molecular weight bioactive subfractions isolated from cultures of wood degrading fungus Cerrena unicolor
Abstract
The aim of this study is to investigate in vitro the anticancer, antioxidant, and antibacterial activities of three low molecular weight subfractions I, II and III isolated from secondary metabolites produced by the wood degrading fungus Cerrena unicolor. The present study demonstrated that the low molecular weight subfractions III exhibited the strongest inhibitory activity towards breast carcinoma cells MDA-MB-231, prostatic carcinoma cells PC3, and breast cancer cells MCF7 with the half-maximal inhibitory concentration (IC50) value of 52,25 μg/mL, 60,66 μg/mL, and 54,92 μg/mL, respectively. The highest percentage of inhibition was noted at a concentration of 300 μg/mL in all the examined tumor lines. A significant percentage (59.08%) of ex-LMSIII inhibition of the MDA-MB-231 tumor line was reached at a concentration of 15 μg/ml, while the concentration applied did not affect normal human fibroblast cells. The low molecular weight subfraction III was the most effective and additionally showed the highest free radical 1,1-diphenyl-2-picryl-hydrazyl scavenging activity (IC50 20.39 μg/mL) followed by the low molecular weight subfraction I (IC50 64.14 μg/mL) and II (IC50 49.22 μg/mL). The antibacterial activity of the tested preparations was evaluated against three microorganisms: Bacillus subtilis, Staphylococcus aureus, and Escherichia coli. The MIC minimal inhibitory concentration (MIC) values for the low molecular weight subfraction I, II, and III showed a stronger inhibition effect on S. aureus than on B. subtilis and E. coli cells. The MIC values for the low molecular weight subfraction II against S. aureus, B. subtilis, and E. coli were 6.25, 12.5, and 100 mg/mL, respectively.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Chen YJ, Jiang S, Jin YX, Yin YL, Yu GJ, Lan XQ, et al. Purification and characterization of an antitumor protein with deoxyribonuclease activity from edible mushroom Agrocybe aegerita. Mol Nutr Food Res. 2012;56: 1729–1738. doi: 10.1002/mnfr.201200316 - DOI - PubMed
-
- Xu T, Beelman RB. The bioactive compounds in medicinal mushrooms have potential protective effects against neurodegenerative diseases. Adv Food Technol Nutr Sci Open J. 2015;1(2): 62–65.
-
- Liu K, Wang J, Zhao L, Wang Q. Anticancer, antioxidant and antibiotic activities of mushroom Ramaria flava. Food Chem Toxicol. 2013;58: 375–380. doi: 10.1016/j.fct.2013.05.001 - DOI - PubMed
-
- Worthington J, Rashid S. The therapeutic potential of mushroom extracts In Natural Products as Future Medicinal Agents. Old City Publishing Inc., USA, 2009.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
